Design, synthesis and structure-activity relationships of new triazole derivatives containing N-substituted phenoxypropylamino side chains

European Journal of Medicinal Chemistry
Shengzheng WangChunquan Sheng

Abstract

The incidence of invasive fungal infections and resistance to antifungal agents is increasing dramatically. It is highly desirable to develop novel azoles with improved biological profiles. The structure-activity relationship (SAR) of the N-substitutions was investigated in this study. In vitro antifungal activities revealed that sterically large groups were not favored for the N-substitutions. The removal of the N-substitutions had little effect on the antifungal activity. Two compounds with free amine group (i.e.9a and 10a) showed excellent activity with broad antifungal spectrum. The SAR results were supported by molecular docking and the N-substitutions were found to be important for the conformation of the side chains. The SAR and binding mode of the azoles are useful for further lead optimization.

References

Nov 4, 2000·Expert Opinion on Investigational Drugs·H L HoffmanM E Klepser
May 23, 2003·Antimicrobial Agents and Chemotherapy·Javier CapillaJosep Guarro
Oct 16, 2004·Expert Review of Anti-infective Therapy·Raymond Cha, Jack D Sobel
Apr 12, 2005·Eukaryotic Cell·Gordon RamageJosé L López-Ribot
Apr 14, 2006·Journal of Medicinal Chemistry·Chunquan ShengJiaguo Lü
May 26, 2006·Journal of Medicinal Chemistry·René Thomsen, Mikael H Christensen
Feb 5, 2009·PLoS Neglected Tropical Diseases·Chiung-Kuang ChenLarissa M Podust
Sep 15, 2009·Bioorganic & Medicinal Chemistry Letters·Wenya WangWannian Zhang
Oct 7, 2009·Expert Review of Anti-infective Therapy·Maria Teresa FeraAngelina De Sarro
Feb 13, 2010·Journal of Molecular Biology·Natallia StrushkevichHee-Won Park
Feb 16, 2010·Odontology·Masakazu NiimiRichard D Cannon
Apr 7, 2010·Bioorganic & Medicinal Chemistry Letters·Yulan XuWannian Zhang
Oct 19, 2010·European Journal of Medicinal Chemistry·Wenya WangChunquan Sheng
May 3, 2011·European Journal of Medicinal Chemistry·Xiaoyun ChaiQingyan Sun
May 19, 2011·Chemical Biology & Drug Design·Chunquan ShengWannian Zhang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Central Nervous System Fungal Infections

Central nervous system fungal infections are rare and typically occur in immunocompromised patients, such as those with HIV infection or transplant recipients. Discover the latest research on central nervous system fungal infections here.